Human T-Cell Lymphotropic Virus 1, 2 (HTLV-1/HTLV-2) Antibodies, Preliminary Test With Confirmation

Create a Free Account to View Prices

Category:

Turnaround Time: 1 -4 days
CPT Code: 86790
Test Type: 2 mL Serum or plasma
Reference Range:

Negative

Overview:

Screen patients for infection with human T-lymphotropic virus and, if positive, confirm infection with either HTLV-1 or HTLV-2.

HTLV-1 or HTLV-2 immunoblot testing should only be performed on patient specimens previously found positive for HTLV infection by immunoassay (EIA). HTLV-1 or HTLV-2 immunoblot testing should only be performed on patient specimens previously found positive for HTLV infection by immunoassay (EIA).

Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen IS. High rate of HTLV-II infection in seropositive drug abusers in New Orleans. Science. 1989 Apr 28; 244(4903):471-475. PubMed 2655084

Manns A, Blattner WA. The epidemiology of the human T-cell lymphotropic virus type I and type II: Etiologic role in human disease. Transfusion. 1991 Jan; 31(1):67-75 (review). PubMed 1986467

Wong-Staal F, Gallo RC. Human T-lymphotropic retroviruses. Nature. 1985 Oct 3-9; 317(6036):395-403. PubMed 2413364

Yoshida M. Human leukemia virus associated with adult T-cell leukemia. Gan. 1983 Dec; 74(6):777-789. PubMed 6321284

Collection Details:

Collection Instructions:

Red-top tube, gel-barrier tube, or lavender-top (EDTA) tube.

Centrifuge sample to separate serum or plasma. For non-gel-barrier tubes, transfer serum or plasma to a plastic transport tube.

Refrigerate. Stable refrigerated for 14 days or frozen for six months.